# Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2

> **NCT06694012** · — · RECRUITING · sponsor: **Osaka Metropolitan University** · enrollment: 2000 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Type 2 Diabetes
- Diabetes Mellitus
- Hypertension
- Hyperglycemia
- Hyperlipidemia
- Dyslipidemia
- Hyperuricemia or Gout
- Hyperuricemia, Gout
- Obesity
- Obesity/Epidemiology
- Obesity, Abdominal
- Central Obesity
- Visceral Fat
- Chronic Kidney Disease(CKD)
- Atherosclerosis
- Metabolic Syndrome
- Hepatic Steatosis
- Insulin Sensitivity/Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06694012
- **Lead sponsor:** Osaka Metropolitan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2050-03-31
- **Final completion:** 2050-03-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2024-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06694012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06694012, "Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06694012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*